Cargando…
Influence of drug safety advisories on drug utilisation: an international interrupted time series and meta-analysis
OBJECTIVE: To evaluate the association between regulatory drug safety advisories and changes in drug utilisation. DESIGN: We conducted controlled, interrupted times series analyses with administrative prescription claims data to estimate changes in drug utilisation following advisories. We used rand...
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899478/ https://www.ncbi.nlm.nih.gov/pubmed/35058332 http://dx.doi.org/10.1136/bmjqs-2021-013910 |
_version_ | 1784663925843820544 |
---|---|
author | Morrow, Richard L Mintzes, Barbara Souverein, Patrick C De Bruin, Marie L Roughead, Elizabeth Ellen Lexchin, Joel Kemp-Casey, Anna Puil, Lorri Sketris, Ingrid Mangin, Dee Hallgreen, Christine E Pearson, Sallie-Anne Lopert, Ruth Bero, Lisa Ofori-Asenso, Richard Gnjidic, Danijela Sarpatwari, Ameet Perry, Lucy T Dormuth, Colin R |
author_facet | Morrow, Richard L Mintzes, Barbara Souverein, Patrick C De Bruin, Marie L Roughead, Elizabeth Ellen Lexchin, Joel Kemp-Casey, Anna Puil, Lorri Sketris, Ingrid Mangin, Dee Hallgreen, Christine E Pearson, Sallie-Anne Lopert, Ruth Bero, Lisa Ofori-Asenso, Richard Gnjidic, Danijela Sarpatwari, Ameet Perry, Lucy T Dormuth, Colin R |
author_sort | Morrow, Richard L |
collection | PubMed |
description | OBJECTIVE: To evaluate the association between regulatory drug safety advisories and changes in drug utilisation. DESIGN: We conducted controlled, interrupted times series analyses with administrative prescription claims data to estimate changes in drug utilisation following advisories. We used random-effects meta-analysis with inverse-variance weighting to estimate the average postadvisory change in drug utilisation across advisories. STUDY POPULATION: We included advisories issued in Canada, Denmark, the UK and the USA during 2009–2015, mainly concerning drugs in common use in primary care. We excluded advisories related to over-the-counter drugs, drug-drug interactions, vaccines, drugs used primarily in hospital and advisories with co-interventions within ±6 months. MAIN OUTCOME MEASURES: Change in drug utilisation, defined as actual versus predicted percentage change in the number of prescriptions (for advisories without dose-related advice), or in the number of defined daily doses (for dose-related advisories), per 100 000 population. RESULTS: Among advisories without dose-related advice (n=20), the average change in drug utilisation was −5.83% (95% CI −10.93 to –0.73; p=0.03). Advisories with dose-related advice (n=4) were not associated with a statistically significant change in drug utilisation (−1.93%; 95% CI −17.10 to 13.23; p=0.80). In a post hoc subgroup analysis of advisories without dose-related advice, we observed no statistically significant difference between the change in drug utilisation following advisories with explicit prescribing advice, such as a recommendation to consider the risk of a drug when prescribing, and the change in drug utilisation following advisories without such advice. CONCLUSIONS: Among safety advisories issued on a wide range of drugs during 2009–2015 in 4 countries (Canada, Denmark, the UK and the USA), the association of advisories with changes in drug utilisation was variable, and the average association was modest. |
format | Online Article Text |
id | pubmed-8899478 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-88994782022-03-22 Influence of drug safety advisories on drug utilisation: an international interrupted time series and meta-analysis Morrow, Richard L Mintzes, Barbara Souverein, Patrick C De Bruin, Marie L Roughead, Elizabeth Ellen Lexchin, Joel Kemp-Casey, Anna Puil, Lorri Sketris, Ingrid Mangin, Dee Hallgreen, Christine E Pearson, Sallie-Anne Lopert, Ruth Bero, Lisa Ofori-Asenso, Richard Gnjidic, Danijela Sarpatwari, Ameet Perry, Lucy T Dormuth, Colin R BMJ Qual Saf Original Research OBJECTIVE: To evaluate the association between regulatory drug safety advisories and changes in drug utilisation. DESIGN: We conducted controlled, interrupted times series analyses with administrative prescription claims data to estimate changes in drug utilisation following advisories. We used random-effects meta-analysis with inverse-variance weighting to estimate the average postadvisory change in drug utilisation across advisories. STUDY POPULATION: We included advisories issued in Canada, Denmark, the UK and the USA during 2009–2015, mainly concerning drugs in common use in primary care. We excluded advisories related to over-the-counter drugs, drug-drug interactions, vaccines, drugs used primarily in hospital and advisories with co-interventions within ±6 months. MAIN OUTCOME MEASURES: Change in drug utilisation, defined as actual versus predicted percentage change in the number of prescriptions (for advisories without dose-related advice), or in the number of defined daily doses (for dose-related advisories), per 100 000 population. RESULTS: Among advisories without dose-related advice (n=20), the average change in drug utilisation was −5.83% (95% CI −10.93 to –0.73; p=0.03). Advisories with dose-related advice (n=4) were not associated with a statistically significant change in drug utilisation (−1.93%; 95% CI −17.10 to 13.23; p=0.80). In a post hoc subgroup analysis of advisories without dose-related advice, we observed no statistically significant difference between the change in drug utilisation following advisories with explicit prescribing advice, such as a recommendation to consider the risk of a drug when prescribing, and the change in drug utilisation following advisories without such advice. CONCLUSIONS: Among safety advisories issued on a wide range of drugs during 2009–2015 in 4 countries (Canada, Denmark, the UK and the USA), the association of advisories with changes in drug utilisation was variable, and the average association was modest. BMJ Publishing Group 2022-03 2022-01-20 /pmc/articles/PMC8899478/ /pubmed/35058332 http://dx.doi.org/10.1136/bmjqs-2021-013910 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Original Research Morrow, Richard L Mintzes, Barbara Souverein, Patrick C De Bruin, Marie L Roughead, Elizabeth Ellen Lexchin, Joel Kemp-Casey, Anna Puil, Lorri Sketris, Ingrid Mangin, Dee Hallgreen, Christine E Pearson, Sallie-Anne Lopert, Ruth Bero, Lisa Ofori-Asenso, Richard Gnjidic, Danijela Sarpatwari, Ameet Perry, Lucy T Dormuth, Colin R Influence of drug safety advisories on drug utilisation: an international interrupted time series and meta-analysis |
title | Influence of drug safety advisories on drug utilisation: an international interrupted time series and meta-analysis |
title_full | Influence of drug safety advisories on drug utilisation: an international interrupted time series and meta-analysis |
title_fullStr | Influence of drug safety advisories on drug utilisation: an international interrupted time series and meta-analysis |
title_full_unstemmed | Influence of drug safety advisories on drug utilisation: an international interrupted time series and meta-analysis |
title_short | Influence of drug safety advisories on drug utilisation: an international interrupted time series and meta-analysis |
title_sort | influence of drug safety advisories on drug utilisation: an international interrupted time series and meta-analysis |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899478/ https://www.ncbi.nlm.nih.gov/pubmed/35058332 http://dx.doi.org/10.1136/bmjqs-2021-013910 |
work_keys_str_mv | AT morrowrichardl influenceofdrugsafetyadvisoriesondrugutilisationaninternationalinterruptedtimeseriesandmetaanalysis AT mintzesbarbara influenceofdrugsafetyadvisoriesondrugutilisationaninternationalinterruptedtimeseriesandmetaanalysis AT souvereinpatrickc influenceofdrugsafetyadvisoriesondrugutilisationaninternationalinterruptedtimeseriesandmetaanalysis AT debruinmariel influenceofdrugsafetyadvisoriesondrugutilisationaninternationalinterruptedtimeseriesandmetaanalysis AT rougheadelizabethellen influenceofdrugsafetyadvisoriesondrugutilisationaninternationalinterruptedtimeseriesandmetaanalysis AT lexchinjoel influenceofdrugsafetyadvisoriesondrugutilisationaninternationalinterruptedtimeseriesandmetaanalysis AT kempcaseyanna influenceofdrugsafetyadvisoriesondrugutilisationaninternationalinterruptedtimeseriesandmetaanalysis AT puillorri influenceofdrugsafetyadvisoriesondrugutilisationaninternationalinterruptedtimeseriesandmetaanalysis AT sketrisingrid influenceofdrugsafetyadvisoriesondrugutilisationaninternationalinterruptedtimeseriesandmetaanalysis AT mangindee influenceofdrugsafetyadvisoriesondrugutilisationaninternationalinterruptedtimeseriesandmetaanalysis AT hallgreenchristinee influenceofdrugsafetyadvisoriesondrugutilisationaninternationalinterruptedtimeseriesandmetaanalysis AT pearsonsallieanne influenceofdrugsafetyadvisoriesondrugutilisationaninternationalinterruptedtimeseriesandmetaanalysis AT lopertruth influenceofdrugsafetyadvisoriesondrugutilisationaninternationalinterruptedtimeseriesandmetaanalysis AT berolisa influenceofdrugsafetyadvisoriesondrugutilisationaninternationalinterruptedtimeseriesandmetaanalysis AT oforiasensorichard influenceofdrugsafetyadvisoriesondrugutilisationaninternationalinterruptedtimeseriesandmetaanalysis AT gnjidicdanijela influenceofdrugsafetyadvisoriesondrugutilisationaninternationalinterruptedtimeseriesandmetaanalysis AT sarpatwariameet influenceofdrugsafetyadvisoriesondrugutilisationaninternationalinterruptedtimeseriesandmetaanalysis AT perrylucyt influenceofdrugsafetyadvisoriesondrugutilisationaninternationalinterruptedtimeseriesandmetaanalysis AT dormuthcolinr influenceofdrugsafetyadvisoriesondrugutilisationaninternationalinterruptedtimeseriesandmetaanalysis |